Skip to content

Clinical trials

Phase 2/3 COVID-19 trials with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: COVID-19 Phase: Phase 2/3 Status: Unknown status Clear all

78 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
202034
202127
202215
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status78

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Cairo University4
Tanta University3
Hospital Universitario San Ignacio2
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran2
Yantai Patronus Biotech Co., Ltd.2
ANRS, Emerging Infectious Diseases1
Administracion Nacional de Laboratorios e Institutos de Salud Dr. Carlos G. Malbran1
Ain Shams University1
Al-Neelain University1
Amsterdam UMC, location VUmc1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
COVID-1978
Coronavirus Infections9
Cytokine Release Syndrome3
Severe Acute Respiratory Syndrome3
Pneumonia2
Respiratory Tract Infections2
Virus Diseases2
Infections1
Lymphoma, Follicular1
Major Depressive Disorder1

Trials

Showing 1 to 25 of 78. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.